1298 Radiomics features to predict immune checkpoint inhibitor-related pneumonitis (CIP) in NSCLC patients treated with immunotherapy

Eitemau Tebyg

• 1298 Radiomics features to predict immune checkpoint inhibitor-related pneumonitis (CIP) in NSCLC patients treated with immunotherapy
  gan: Young Kwang Chae, et al.
  Cyhoeddwyd: (2023-11-01)
• 38 Serum proteomics signature and its association with immune-related toxicities and survival in patients with non-small cell lung cancers (NSCLC) receiving immunotherapy
  gan: Young Kwang Chae, et al.
  Cyhoeddwyd: (2023-11-01)
• Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly differentiated thyroid carcinoma with PTEN mutation: a case report and literature review
  gan: Youjin Oh, et al.
  Cyhoeddwyd: (2024-01-01)
• E.C. Dijkhof, J.G. Kruisheer, Oorkondenboek van Holland en Zeeland tot 1299, V, 1291 tot 1299
  gan: W. Prevenier
  Cyhoeddwyd: (2007-01-01)
• The role and underlying mechanism of miR-1299 in cancer
  gan: Deng Kaiyuan, et al.
  Cyhoeddwyd: (2021-07-01)